FDG PET/CT检出卵巢癌孤立性小脑转移
Solitary Cerebellar Metastasis of Ovarian Cancer Detected by FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2020-01-01
本文报告一例58岁女性卵巢癌患者,在肿瘤减灭术和化疗后9个月出现头痛,血清CA125升高;FDG PET/CT显示右侧小脑高代谢肿块,手术病理证实为卵巢癌小脑转移。卵巢癌孤立性小脑转移非常罕见。
要点
- 卵巢癌患者随访中出现头痛及CA125升高时,需警惕罕见部位转移。
- FDG PET/CT有助于识别卵巢癌的潜在恶性转移灶。
- 小脑肿块手术病理可确诊卵巢癌转移。
核心结论
- FDG PET/CT检出了卵巢癌治疗后9个月出现的右侧小脑孤立性高代谢转移灶,并经手术病理证实。
研究设计与样本
- 个案报告:58岁女性卵巢癌患者,肿瘤减灭术和化疗后9个月出现头痛。
主要发现
- 患者血清CA125水平升高。
- FDG PET/CT显示右侧小脑高代谢肿块。
- 小脑肿块手术切除后病理证实为卵巢癌转移。
临床怎么用
- 卵巢癌治疗后出现头痛且CA125升高时,可考虑FDG PET/CT评估潜在恶性病灶。
局限性
- 本文为单个病例报告,未提供样本量、随访或疗效比较数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ovarian cancer with solitary metastasis to the cerebellum is very rare. We presented a 58-year-old woman complaining of headaches 9 months after debulking surgery and chemotherapy due to ovarian cancer. The serum CA125 level was elevated. FDG PET/CT was then recommended to identify potential malignancy and showed a hypermetabolic mass in the right cerebellum. The cerebellar mass was surgically removed, and the pathology confirmed metastasis from ovarian cancer.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Hou G, Jiang Y, Cheng X, et al. Solitary Cerebellar Metastasis of Ovarian Cancer Detected by FDG PET/CT. Clin Nucl Med. 2020. PMID: 31876807. doi:10.1097/RLU.0000000000002838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。